跳至主要内容
临床试验/EUCTR2016-003223-30-DE
EUCTR2016-003223-30-DE进行中(未招募)1 期

Prophylactic treatment of hemiplegic migraine with Lamotrigine

niversity Hospital Tübingen0 个研究点目标入组 28 人开始时间: 2017年2月20日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
28

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • Diagnosis of hemiplegic migraine according to the International Classification of Headache Disorders 3rd edition (beta version) (ICHD-IIIß)
  • At least three hemiplegic migraine attacks during the observational phase (i.e. within the 12 months before initiation of lamotrigine ther-apy)
  • Age > 18 years
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 22
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 6

排除标准

  • Co-existing primary headache disorders
  • Patients on prophylactic migraine medication within six months before beginning of the trial
  • Pregnancy, breast feeding and ineffective contraception is present
  • Cardiac, hepatic or renal disease
  • Skin disease
  • Suicidal ideation in the last two years

研究者

发起方
niversity Hospital Tübingen

相似试验

Prophylactic treatment of hemiplegic migraine with... | 临床试验